Carlson’s Double Black Diamond Fund Is Still In The Green For 2022 Despite Challenging Months [Exclusive]

Is This NYSE American Biopharma (ATNM) Ready To Burst Onto The Scene? Biotech stocks can start as little known afterthoughts and turn into explosive disruptors on the cusp of revolutionizing medicine in months, weeks, or even days. That's why we put together this comprehensive research report on Actinium Pharmaceuticals. See Full Report here >>> Carlson's Double Black Diamond Fund Is Still In The Green For 2022 Despite Challenging Months [Exclusive] Clint Carlson's Double Black Diamond fund declined 1.69% net for September, a solid return at a time when most other hedge funds are rapidly shedding capital. The September return brings the fund's year-to-date return to 2.76% — keeping Carlson's Double Black Diamond fund as one of a relatively small number of hedge funds in the […] Read More Kimberly Clark Products Post Weak Quarter Despite Raising Prices Organic sales rose by $5 and sales increased by 1% year over year. North American organic sales fell by 2% and increased 11%. Operating profits fell slightly to $655 million, down from $657 million in the same quarter last year. Kimberly Clark Corporation (NYSE:KMB) witnessed rising costs, slowing sales due to weakness in consumer demand […] Read More Why Is Kraft Heinz Stock Moving Higher? It's A Great Bargain Kraft Heinz is a deep value and high-yield in the consumer staples sector. The company continues to outperform expectations and just raised guidance. Price action is moving and may soon cross an important technical level. The Kraft Heinz Company (NASDAQ:KHC) is a great buy, but just like with all stocks, it's relative to each investor. […] Read More Is This The Bottom For Canopy Growth Corporation? Canopy Growth Company surged 25% but don't hold your breath for higher prices. An acquisition of Acreage Holdings leading to the US market sparked the surge. The full realization of potential relies on US legalization and the mid-term elections may not pan out. If you are wondering if this is the bottom for Canopy Growth […] Read More Vaxcyte (PCVX) Has Rallied 70% This Week on Trial Results. Is There More Upside? Discusses the trial results, analyst commentary and Fintel platform analysis On Monday, biopharmaceutical firm Vaxcyte Inc (NASDAQ:PCVX) led the market higher as it rose 60.4% higher closing at $33 after reaching as high as $36.10 intra-day after releasing topline data from a proof-of-concept study of VAX-24. Shares continued their gains on Tuesday, rising a further […] Read More Newton's Law of Stock Market Motion Privacy Policy | Advertiser Disclosure Newton's First Law of Motion states that an object in motion tends to stay in motion unless an external force acts upon it. In the year 2022, we have been reminded how efficiently the stock market facilitates moving money from impatient people to patient people. A bull market in stocks tends to stay in motion […] Read More Unsubscribe | Update your profile | 347 Fifth Avenue Suite 1402-390 , New York, NY 10016